Ventolin and Pentoxifylline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ventolin (albuterol) and Pentoxifylline (pentoxifylline). Common drug interactions include macular degeneration among females and lung disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Ventolin and Pentoxifylline. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.

What is Pentoxifylline?

Pentoxifylline has active ingredients of pentoxifylline. eHealthMe is studying from 5,997 Pentoxifylline users. Check the latest studies of Pentoxifylline.



On Jul, 26, 2026

24 people who take Ventolin and Pentoxifylline together, and have interactions are studied.

Ventolin and Pentoxifylline drug interactions.

What are the common drug interactions of Ventolin and Pentoxifylline, by gender? *:

female:

  1. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Neoplasm (tumour)
  4. Oedema (fluid collection in tissue)
  5. Oral discomfort (pain or irritation in mouth)
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  9. Pneumonia
  10. Proctalgia (pain in the rectum)

male:

  1. Lung disorder (lung disease)
  2. Body height decreased
  3. Diabetic hyperosmolar coma (diabetes coma due to extremely high blood sugar (glucose) levels; extreme lack of water (dehydration))
  4. Drug ineffective
  5. Dyspnoea (difficult or laboured respiration)
  6. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  7. Infected neoplasm (infected tumour)
  8. Infusion related reaction
  9. Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
  10. Klebsiella infection

What are the common drug interactions of Ventolin and Pentoxifylline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dizziness (excl vertigo)
  2. Dyspnoea (difficult or laboured respiration)
  3. Encephalopathy (functioning of the brain is affected by some agent or condition)
  4. Enteritis (inflammation of the small intestine)
  5. Haematuria (presence of blood in urine)
  6. Haemorrhage (bleeding)
  7. Headache (pain in head)
  8. Hepatocellular damage (liver damage)
  9. Hyperadrenalism (excessive levels of adrenal hormones in the body)
  10. Hypokalaemia (low potassium)

50-59:

  1. Anal pruritus (anal itching)
  2. Back pain
  3. Blood iron decreased
  4. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  5. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  6. Cough
  7. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  8. Drug ineffective
  9. Dyspepsia (indigestion)
  10. Dysphagia (a condition in which swallowing is difficult or painful)

60+:

  1. Drug ineffective
  2. Lung disorder (lung disease)
  3. Hypertension (high blood pressure)
  4. Muscle spasms (muscle contraction)
  5. Pain
  6. Pyrexia (fever)
  7. Renal disorder (kidney disease)
  8. Ulcer
  9. Weight decreased
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 29.17%
  2. Pain: 6 people, 25.00%
  3. Stress And Anxiety: 5 people, 20.83%
  4. High Blood Cholesterol: 5 people, 20.83%
  5. Diabetes: 4 people, 16.67%
  6. High Blood Pressure: 4 people, 16.67%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 16.67%
  8. Peripheral Vascular Disorder: 4 people, 16.67%
  9. Eye Disorder: 3 people, 12.50%
  10. Cardiac Disorder: 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Ventolin and Pentoxifylline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ventolin and Pentoxifylline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pentoxifylline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ventolin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pentoxifylline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol and pentoxifylline (the active ingredients of Ventolin and Pentoxifylline, respectively), and Ventolin and Pentoxifylline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: